The Nasdaq Biotechnology Index fell by more than 1%. Among the constituent stocks, Lyell Immunopharma dropped 11.28%, Vor Biopharma fell 8.16%, Alumis decreased 6.99%, and Oruka Therapeutics declined 7.93%. Meanwhile, Coherus BioSciences rose 6.34%, Pyxis Oncology increased 8.02%, Ultragenyx Pharmaceutical gained 13.59%, and Jyong Biotech surged 43.38%Wallstreetcn·Dec 30, 2025 at 07:31 PMLYEL-5.27%PYXS+6.85%
The Nasdaq Biotechnology Index closed up more than 1.4%. Among the constituent stocks, Cullinan Oncology LLC rose 36.54%, Relay Therapeutics Inc. rose 20.68%, GRAIL rose 18.81%, and Lyell Immunopharma rose 18.71%. Meanwhile, Anavex Life Sciences fell 5.52%, Neumora Therapeutics fell 7.30%, and Arcellx fell 16.89%Wallstreetcn·Nov 24, 2025 at 09:17 PMLYEL-5.27%CGEM-0.92%
The Nasdaq Biotechnology Index closed down over 1.3%Wallstreetcn·Oct 10, 2025 at 08:31 PMOABI+10.07%LYEL-5.27%
